Ligand validation:3ZWM

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3ZWM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZWM_NAD_D_301	50%	22%	0.152	0.904	1.83	1.55	4	7	2	0	100%	1
3ZWM_NAD_A_301	49%	19%	0.165	0.911	2	1.63	5	9	5	0	100%	1
3ZWM_NAD_E_301	44%	14%	0.198	0.925	2.03	1.98	6	12	3	0	100%	1
3ZWM_NAD_C_301	41%	20%	0.186	0.9	1.88	1.66	5	8	2	0	100%	1
3ZWM_NAD_B_301	39%	19%	0.164	0.868	1.93	1.69	4	9	3	0	100%	1
3ZWM_NAD_G_301	32%	18%	0.202	0.874	2.01	1.72	7	10	1	0	100%	1
3I9K_NAD_B_301	36%	23%	0.216	0.912	1.78	1.58	4	8	0	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.